This is a limited company view. Sign up for a Free Trial to see everything.

Revance is committed to the advancement of remarkable science that improves patient outcomes.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Bay Area

Founded

2002

Employees

139

Stage

Public

Total funding

$114M

Last funding

4 years ago

Acquisitions

0

Growth score

195

Mindshare score

123

Scoring

Deals

$10.0M Venture

Oct 24, 2013

$25.6M Series D

Dec 18, 2009

Other Investors

Vivo Capital

Employee Growth

Use Revance Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Revance Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Material Manager
Senior Manager, Pharmaceutical Development
Manager, SEC Reporting and Technical Accounting
QC Manager
Manufacturing Manager
Associate Clinical Trial Manager
Director, Program & Project Management
Corporate Controller & Senior Director of Finance
Sr. Manager, Accounting Operations
Sr. Director, Nonclinical R&D
Validation Manager
Senior Director, Legal
Sr. Director, Human Resources
Director of Validation
Biophyscial Analytical Scientist
Research Scientist
Research Associate
Quality Assurance

Similar Companies

Nuvilex

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R).
Pre-Series A|2 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes